noom med glp-1 Noom: Lose weight and keep

Imaging studies such as plain radiographs, ultrasound, or MRI may be indicated to assess for structural joint abnormalities, inflammatory changes, or other pathology

For patients with chronic kidney disease or heart failure, SGLT2 inhibitors are generally prioritised, with GLP-1 receptor agonists as complementary therapy where appropriate

Insulin allows glucose to be taken up and used by insulin-dependent tissues

Per publicly available announcements, the FDA issued more than 50 warning letters to GLP-1 compounders and manufacturers in September 2025, followed by 30 additional warning letters to telehealth firms in early 2026, targeting false or misleading marketing claims about compounded GLP-1 products

Precautions: Consult a doctor before use if you have health conditions or are taking medications